ライフサイエンスコーパス: osteogenic

1 into osteoblasts at sites that are innately osteogenic.

2 erm culture-induced MSC aging impaired their osteogenic ability and subsequent bony callus formation,

3 mBMSCs with Msx1 and Msx2 genes and compared osteogenic activity and expression levels of several Msx

4 Osteogenic activity in the aortic valve is under the con

5 nalling in C2C12 does not translate into non-osteogenic activity in vivo and BMP10 also induces bone-

6 olecular strategies are toward promoting pro-osteogenic activity of BMP2 while simultaneously suppres

7 In mice, the intrinsic osteogenic activity of ihOCM surpasses bone morphogenic

8 eins are potent stem cell activators and pro-osteogenic agents.

9 Prolonged culture-associated decreases in osteogenic and adipogenic capacity were partially protec

10 g epigenetic modifications that occur during osteogenic and adipogenic differentiation of mouse bone

11 ifferentiation capacity of these stem cells, osteogenic and adipogenic differentiation was achieved.

12 igher expression of SPP1 and LEP, markers of osteogenic and adipogenic differentiation, respectively.

13 drogel constructs can be differentiated down osteogenic and adipogenic lineages, giving rise to self-

14 pression and gene silencing of CypA verified osteogenic and anti-osteoclastic effects.

15 Collectively, CypA dually exerts pro-osteogenic and anti-osteoclastic effects.

16 ogenic (3-4 hours) commitment in contrast to osteogenic and basal cultured conditions.

17 covered that global Notch inhibition reduces osteogenic and chondrogenic differentiation of FCSCs.

18 nges in mesenchymal stem cells (MSCs) during osteogenic and chondrogenic differentiation.

19 istinct subpopulation of MSCs, with enhanced osteogenic and decreased adipogenic differentiation capa

20 scription factor 2-mediated (Runx2-mediated) osteogenic and decreased PPARgamma-dependent adipogenic

21 This process is thought to impair osteogenic and hematopoietic regeneration.

22 concentration for microspheres, the combined osteogenic and mineralization effect of PRP and BMP2 on

23 However, the molecular mechanisms underlying osteogenic and myogenic differentiation by FN in C2C12 p

24 aphy, cell shape and cell differentiation to osteogenic and myogenic lineages.

25 , the authors compared and evaluated the pro-osteogenic and pro-odontogenic effects of 4 small bioact

26 ssive stiffness simultaneously increased the osteogenic and proangiogenic potential of entrapped cocu

27 Cs and ECFCs to simultaneously promote their osteogenic and proangiogenic potential.

28 helial growth factor (VEGF) on the extent of osteogenic and vasculogenic differentiation of human mes

29 ess stem cell markers and have chondrogenic, osteogenic, and adipogenic differentiation ability.

30 o various cells lineages such as adipogenic, osteogenic, and chondrogenic.

31 In ovariectomised mice, the osteogenic benefits of co-treatment on the trabecular bo

32 stem cells and plasmids encoding for either osteogenic (BMP2) or chondrogenic (combination of TGF-be

33 In osteogenic C2C12 cells, P-Panx3 was located on the ER me

34 BMP4 overexpression in non-osteogenic C4-2b PCa cells led to ectopic bone formation

35 , the ability of MOFs to degrade and release osteogenic Ca and Sr ions was investigated.

36 Embryonic osteogenic calvarial cells (EOCCs) were isolated from fe

37 ts on cell viability, or on their subsequent osteogenic capabilities.

38 istry and mechanical stability determine the osteogenic capability of bone implants.

39 BM-MSCs seemed to have low proliferative and osteogenic capacities; therefore, enhancing their qualit

40 afts from aged animals with L-WNT3A restored osteogenic capacity to autografts back to levels observe

41 mouse calvarial cells resulted in increased osteogenic capacity.

42 c progenitor cells (OPCs) but also stimulate osteogenic cell Akt signaling in those OPCs.

43 fibroblasts respond to injury by adopting an osteogenic cell fate and creating damaging calcific depo

44 ression of Runx2 and Col1a1, which are early osteogenic cell markers, on day 10 after the subperioste

45 stem cells that generates high yields of an osteogenic cell-matrix (ihOCM) in vitro.

46 Analogous to bone formation, osteogenic cells are thought to be recruited to the affe

47 differentiation efficiency and they generate osteogenic cells comparable to osteogenic cells derived

48 they generate osteogenic cells comparable to osteogenic cells derived from mesenchymal stromal cells

49 rapeutic paradigms to augment the endogenous osteogenic cells for bone regeneration and the treatment

50 of pro-angiogenic potential of transplanted osteogenic cells for effective cell-mediated bone repair

51 tes potentially due to their derivation from osteogenic cells in the periosteum.

52 n to multiple phenotypes including Lgals3(+) osteogenic cells likely to be detrimental for late-stage

53 Bq for total body, 0.21 +/- 0.15 cGy/MBq for osteogenic cells, and 0.17 +/- 0.15 cGy/MBq for kidneys.

54 y, pretreatment of p38 inhibitor followed by osteogenic challenge impaired osteoblastogenesis via sup

55 te into various lineages in vitro, including osteogenic, chondrogenic, and adipogenic lineages.

56 tly their proliferation or influencing their osteogenic/chondrogenic differentiation.

57 bone sclerosis has been linked to heightened osteogenic commitment of bone marrow stromal cells (BMSC

58 ibition and siRNA knockdown of Ezh2 enhanced osteogenic commitment of MC3T3 preosteoblasts.

59 Osteogenic cultures from Tg mice had reduced differentia

60 n of p53 in Wwox(Deltaosx1) mice rescued the osteogenic defect.

61 anscription proteins (STATs) in myogenic and osteogenic differentiation after FN treatment were also

62 ration and survival capacities, reduction in osteogenic differentiation and a decrease in the ability

63 to investigate the effects of soluble Si on osteogenic differentiation and connexin 43 (CX43) gap ju

64 redox ratio decreased for VICs during early osteogenic differentiation and correlated with biologica

65 alveolar bone regeneration through enhancing osteogenic differentiation and decreasing stromal cell-d

66 rolonged calcifying conditions by inhibiting osteogenic differentiation and increases in nSMase2 thro

67 investigate the action of FN on myogenic and osteogenic differentiation and its impact on signaling p

68 lation of BMP4-pSMAD1/5 signaling, decreased osteogenic differentiation and lowered proliferation cap

69 the regulation of AP-1 pathway genes and for osteogenic differentiation and matrix mineralization.

70 of autophagy before day 3 strongly inhibited osteogenic differentiation and mineralization of ASCs in

71 rated the attachment, spread, proliferation, osteogenic differentiation and mineralization of MC3T3-E

72 acute myeloid leukemia impaired mesenchymal osteogenic differentiation and reduced regulatory molecu

73 dence that 25(OH)D3 at 250-500 nM can induce osteogenic differentiation and that 25(OH)D3 has great p

74 g OA-mediated mesenchymal stromal cell (MSC) osteogenic differentiation are not known.

75 ioactive, capable of stimulating odontogenic/osteogenic differentiation as observed by gene expressio

76 s induced by osteogenic stimuli and promotes osteogenic differentiation at least partly by targeting

77 tion in human smooth muscle cells undergoing osteogenic differentiation attenuated matrix mineralizat

78 that these hESCs/hiPSCs are similar in their osteogenic differentiation efficiency and they generate

79 inB1-EphB2 interaction regulates odontogenic/osteogenic differentiation from dental pulp cells (DPCs)

80 we examined effects of OA on cell viability, osteogenic differentiation in MSCs, and the involvement

81 th in MT, as mediated by enhanced MSC-driven osteogenic differentiation in the jaw bone.

82 g medium, which in turn efficiently enhanced osteogenic differentiation in vitro and osteointegration

83 PRP from alginate beads on BMP2-modified MSC osteogenic differentiation in vitro and sustained releas

84 ated a reduction in cell survival and direct osteogenic differentiation in vitro These effects were m

85 YLL8, both of which increase osteoprogenitor osteogenic differentiation in vitro.

86 NA mediated gene silencing to understand the osteogenic differentiation observed on fibrous scaffolds

87 The osteogenic differentiation of adipose-derived stem cells

88 ively, our findings indicate Cdo1 suppresses osteogenic differentiation of BMSCs, through a potential

89 BMP-2, and promoted robust BMP-2-stimulated osteogenic differentiation of BMSCs.

90 gulation of E2/ER-facilitated BMP-2-directed osteogenic differentiation of BMSCs.

91 bone morphogenetic protein-2/BMP-2-directed osteogenic differentiation of bone marrow stromal cells

92 ontrolled release of Ade and facilitated the osteogenic differentiation of bone mesenchymal progenito

93 significantly improved potential for odonto/osteogenic differentiation of DPSCs both in vivo and in

94 in the process of IFN-gamma-regulated odonto/osteogenic differentiation of DPSCs.

95 marrow stromal cells cultured in microwells, osteogenic differentiation of encapsulated cells depends

96 CSC-HUVEC contact significantly enhanced the osteogenic differentiation of FCSCs.

97 how that cyclic tensile strain both enhances osteogenic differentiation of hASCs while it suppresses

98 odel drug dexamethasone (Dex) to promote the osteogenic differentiation of hASCs.

99 ersed the promoting or suppressing effect of osteogenic differentiation of hBMSCs, respectively, caus

100 e PLZF transcription factor is essential for osteogenic differentiation of hMSCs; however, its regula

101 ary cilia are involved in chemically-induced osteogenic differentiation of human ASC (hASCs) in vitro

102 e expression of miR-101 and its roles in the osteogenic differentiation of human bone marrow-derived

103 e, we investigated the effect of 25(OH)D3 on osteogenic differentiation of human mesenchymal stem cel

104 niques to synergistically improve growth and osteogenic differentiation of human mesenchymal stem cel

105 strated through localized cell spreading and osteogenic differentiation of human mesenchymal stem cel

106 and cartilage homeostasis by influencing the osteogenic differentiation of hypertrophic chondrocytes

107 of RhoA and ROCK activity partially restores osteogenic differentiation of IFT80-deficient OPCs by in

108 The increased osteogenic differentiation of mandibular torus MSCs was

109 well as on the adhesion, proliferation, and osteogenic differentiation of MC3T3-E1 pre-osteoblastic

110 find that cell spreading, proliferation, and osteogenic differentiation of mesenchymal stem cells (MS

111 vealed enhanced focal adhesion formation and osteogenic differentiation of MSCs cultured on positivel

112 bone morphogenetic protein-2 (BMP2) promotes osteogenic differentiation of MSCs.

113 Osteogenic differentiation of primary human vascular smo

114 uring bone healing favours chondrogenic over osteogenic differentiation of skeletal progenitor cells.

115 he potential of plant-produced OPN to induce osteogenic differentiation of stem cells from periodonta

116 ed to have effects on both proliferation and osteogenic differentiation of stem cells.

117 proliferation and enhances the efficiency of osteogenic differentiation of the cells.

118 s did not alter their cytotoxicity or affect osteogenic differentiation of the stem cells.

119 7 (also known as osterix), and thus enhances osteogenic differentiation of these stem cells.

120 In vitro, Lp(a) induced osteogenic differentiation of valvular interstitial cell

121 ranscription (STAT) 3 signaling pathway, and osteogenic differentiation potential.

122 Furthermore, BMP2 mediated MSC osteogenic differentiation was significantly enhance by

123 MSCs exposed to Ag(+) prior to/during osteogenic differentiation were not statistically affect

124 ncreasing vascular smooth muscle cell (VSMC) osteogenic differentiation, ADAM17-induced renal and vas

125 ll LIV signals enhanced hBMSC proliferation, osteogenic differentiation, and upregulated genes associ

126 Genes crucial for osteogenic differentiation, bone matrix formation and mi

127 from Clec11a-deficient mice showed impaired osteogenic differentiation, but normal adipogenic and ch

128 JNK inactivation suppresses osteogenic differentiation, but robustly induces osteopo

129 Osterix (Osx) is a marker of osteogenic differentiation, expressed in skeletal progen

130 d in response to culture in complete growth, osteogenic differentiation, or adipogenic differentiatio

131 did not affect cell viability, apoptosis, or osteogenic differentiation, perhaps due to increased exp

132 Ppia(-/-) osteoblasts demonstrate decreased osteogenic differentiation, whereas Ppia(-/-) osteoclast

133 MiR-101 depletion suppressed osteogenic differentiation, whereas the overexpression o

134 role of magnesium in promoting CGRP-mediated osteogenic differentiation, which suggests the therapeut

135 Interestingly, increased expression of osteogenic differentiation-related genes, including OSX,

136 its diverse biological activities including, osteogenic differentiation.

137 PN secretory phenotype at the early stage of osteogenic differentiation.

138 ich is dependent on PLZF and is required for osteogenic differentiation.

139 sor of matrix viscoelasticity that regulates osteogenic differentiation.

140 ortic valve interstitial cells (VICs) during osteogenic differentiation.

141 inant Wnt5a to MSCs was sufficient to impair osteogenic differentiation.

142 Notch signaling fully blocked OA induced MSC osteogenic differentiation.

143 and migration of DPSCs, but abrogated odonto/osteogenic differentiation.

144 ease, resulting in better cell in-growth and osteogenic differentiation.

145 l properties, drug release, degradation, and osteogenic differentiation.

146 hanism of autophagy in mesenchymal stem cell osteogenic differentiation.

147 iRNAs) are involved in multiple processes of osteogenic differentiation.

148 l stem cells and associates with an impaired osteogenic differentiation.

149 psazepine and SKF96365, which also inhibited osteogenic differentiation.

150 onist-SAG rescued OAF cell proliferation and osteogenic differentiation.

151 unneling formation, vascular cell growth and osteogenic differentiation.

152 ces gene expression patterns associated with osteogenic differentiation.

153 bioprintable material and achieve effective osteogenic differentiation.

154 atrix remodeling is associated with enhanced osteogenic differentiation.

155 Porphyromonas gingivalis stimulation during osteogenic differentiation.

156 letal tension on osteoprogenitors leading to osteogenic differentiation.

157 1.0 x 10(7)/mL stem cells exhibited the best osteogenic effect both in vitro and in vivo.

158 hat high-frequency acceleration (HFA) has an osteogenic effect on healthy alveolar bone.

159 In this study, the in vitro osteogenic effects of polydopamine-laced hydroxyapatite

160 ition of Notch signaling is required for its osteogenic effects on MSCs.

161 studies demonstrate the importance of the 3D osteogenic-endothelial niche interaction in bone regener

162 Subsequently, PLZF was recruited to osteogenic enhancers, influencing H3K27 acetylation and

163 Additionally, we also demonstrate the osteogenic environment around brain calcifications in ge

164 The addition of recombinant mDKK1 switched osteogenic ESC differentiation toward chondrogenic diffe

165 eural EGFL-like 1 (Nell-1) is a well-studied osteogenic factor that has comparable osteogenic potency

166 re implanted ectopically in combination with osteogenic factors into mice to generate a physiological

167 ation, these IS cells differentially express osteogenic factors, mechanosensitive genes, and signalin

168 of stem cells with the controlled release of osteogenic factors, within a mechanically-strong biomate

169 This ultimately induces osteogenic fate commitment.

170 Mechanical signals promote osteogenic fate through a primary cilia-mediated mechani

171 a valuable experimental tool to distinguish osteogenic from dentinogenic cells, thereby providing an

172 scence, increased SSPC number, and increased osteogenic function.

173 and expression of nearby genes important for osteogenic function.

174 yses of Mkx(-/-) PDL revealed an increase in osteogenic gene expression and no change in PDL- and inf

175 graphy on altering cell-cell interaction and osteogenic gene expression at the single cell level.

176 roliferation with a concomitant reduction of osteogenic gene expression, and prevention of craniosyno

177 We assayed osteogenic gene expression, capacity to deposit and mine

178 hat in mobile MPCs, chromatin regions around osteogenic genes are open, whereas in immobile MPCs, reg

179 y was sufficient to induce the expression of osteogenic genes in betaglycan-ablated MSCs.

180 t the CaSr-MOFs by themselves can upregulate osteogenic genes in hMSCs, which is the first time to ou

181 1, which regulates the expression of key pro-osteogenic genes such as RUNX2 and BMP2.

182 verexpressing human PDL fibroblasts, whereas osteogenic genes were downregulated.

183 n was associated with elevated expression of osteogenic genes, decreased expression of pro-inflammato

184 sion of complement factors, ECM proteins and osteogenic genes.

185 These condensations commit to an osteogenic identity and suppress chondrogenesis.

186 cing analyses, we found that genes vital for osteogenic identity were linked to RUNX2, C/EBPbeta, ret

187 med to identify the transcriptome profile of osteogenic induced ASCs to understand the associated gen

188 4, 14, and 24 in terms of responsiveness to osteogenic induction media and/or stimulation with rhPTH

189 Alizarin Red staining showed that osteogenic induction medium (OIM) by itself and in combi

190 ing JAK1-STAT1 phosphorylation levels, while osteogenic induction was enhanced by p38MAPK dependent S

191 ession in PDL-CD105(+) cells after 7 days of osteogenic induction, although mineral nodule formation

192 PCL+FA and PCL scaffolds to investigate the osteogenic inductive ability of FA crystals and we obser

193 onse in a FZD-selective fashion, enhance the osteogenic lineage commitment of primary mouse and human

194 ndeed, biophysical stimuli potently regulate osteogenic lineage commitmentin vitro In this study, we

195 anobiology model, mechanical signals enhance osteogenic lineage commitmentin vivoand that the primary

196 ng a lineage autonomous function of Shox2 in osteogenic lineage fate determination and skeleton patte

197 wth factors to differentiate hMSCs toward an osteogenic lineage in situ.

198 ls to bone surfaces and the commitment to an osteogenic lineage of these cellsin vivo Furthermore, we

199 While aging impairs the osteogenic lineage, high-fat diet feeding activates expa

200 Harnessing an osteogenic lineage-specific Shox2 inactivation approach

201 ific result of Shox2 loss of function in the osteogenic lineage.

202 o accelerate the cell differentiation toward osteogenic lineage.

203 he cellular identities of the adipogenic and osteogenic lineages of the bone.

204 wers the threshold for commitment to chondro/osteogenic lineages.

205 he endochondral/cartilaginous phase promoted osteogenic marker expression.

206 reased in vitro bone formation and decreased osteogenic marker gene expression; promoter methylation

207 as well as gene expression of Alpl and other osteogenic marker genes in mouse osteoblasts and mesench

208 The expression level of early osteogenic marker genes, ALP, Runx2, and type I collagen

209 ed surfaces that upregulate expression of an osteogenic marker, we used genetic crossover and random

210 were accompanied by increased expression of osteogenic markers and intramembranous bone formation an

211 tal dimension correlated with structural and osteogenic markers as well as measures of nuclear morpho

212 unced upregulation of osteopontin and RUNX2 (osteogenic markers), CD63, AnX2 (sEV markers) and ALP ex

213 The osteogenic markers, alkaline phosphatase, secreted phosp

214 further required for eventual expression of osteogenic markers, and RARG-antagonist strongly drives

215 ion conditions, as evidenced by increases in osteogenic markers, including Runt-related transcription

216 of TdT(OSX)+ cells expresses fibroblast and osteogenic markers.

217 Samples were cultured in vitro in osteogenic media (OM) for 13 d and then implanted subcut

218 hear for 2 days and 3 &7 days in regular and osteogenic media, respectively.

219 times (every two days) on hASCs cultured in osteogenic medium over three weeks.

220 althy controls and cultured up to 24 d using osteogenic medium with standard phosphate concentration.

221 A common molecular marker for all osteogenic mesenchymal progenitors has not been identifi

222 Herein, we describe a highly osteogenic MSC line generated from induced pluripotent s

223 lial cell spheres promote bone healing in an osteogenic niche.

224 appropriately primed to differentiate along osteogenic or chondrogenic lineage.

225 cacy and safety of periodontally accelerated osteogenic orthodontics (PAOO) with "Piezocision"-a mini

226 ly increased and expanded expression of many osteogenic pathway genes, including Bmp3, Bmp5, Bmp7, Me

227 that suggested a default preference for the osteogenic pathway; however, these patterns were rapidly

228 These bone-targeted, osteogenic peptides are well suited for current tissue-s

229 experiments showed that H19 induces a strong osteogenic phenotype by altering the NOTCH1 pathway.

230 n advanced lesions, including Klf4-dependent osteogenic phenotypes likely to contribute to plaque cal

231 pressed T63-induced RUNX2 expression and the osteogenic phenotypes.

232 tudied osteogenic factor that has comparable osteogenic potency with the Food and Drug Administration

233 ith limited differentiation capacity, having osteogenic potential (PC-O) or angiogenic support functi

234 esenchymal stem/stromal cells (MSCs) possess osteogenic potential and produce numerous angiogenic gro

235 DLX3 mutation (c.533 A>G; Q178R) attenuates osteogenic potential and senescence of bone mesenchymal

236 PDLMSCs demonstrated more osteogenic potential compared to GMSCs with strong miner

237 growth factor-associated genes and enhances osteogenic potential in PDLSCs.

238 al that nuclear mechanosensing controls hMSC osteogenic potential mediated by HDAC epigenetic remodel

239 ASA at 1,000 muM enhances osteogenic potential of PDLSCs.

240 d within a bone defect site to determine the osteogenic potential of the skeletal-endothelial cell un

241 The osteogenic potential was evaluated through mineralizatio

242 aspirin (ASA) on the proliferative capacity, osteogenic potential, and expression of growth factor-as

243 Here, we report DP-MSCs exhibit increased osteogenic potential, possess decreased adipogenic poten

244 r perivascular MSC/osteoprogenitors and high osteogenic potential.

245 liferation, colony formation, migration, and osteogenic potential.

246 sed bone formation by compensating decreased osteogenic potentials with more generations and extended

247 f early response genes and inhibition of the osteogenic process.

248 e role of exogenous factors in driving these osteogenic processes will aid the development of better

249 ry of ligands that not only bind strongly to osteogenic progenitor cells (OPCs) but also stimulate os

250 and basic fibroblast growth factor in these osteogenic progenitor cells are markedly different, sugg

251 a femur non-union fracture demonstrate only osteogenic progenitor cells with higher pro-angiogenic p

252 lpha and Sca-1 than the Sca-1-negative adipo-osteogenic progenitors, which create a niche for hematop

253 yltransferase, suppressed differentiation of osteogenic progenitors.

254 expression of this lncRNA, which promotes an osteogenic program by interfering with the expression of

255 ion of several Wnt genes, BMP2 activates the osteogenic program largely independently of de novo Wnt

256 osteolytic program in KLF4 null cells to an osteogenic program.

257 Importantly we observed osteogenic programming of gene expression by released GE

258 To examine the effects of osteogenic promoting conditions on DRP1 and whether DRP1

259 We used a rat model to test the osteogenic properties of bone marrow-derived mesenchymal

260 out undesirable estrogenic activity and with osteogenic properties, we are now interested in validati

261 Assessment of osteogenic protein expression was performed to confirm d

262 s and a higher expression of osteocalcin -an osteogenic protein known to be promoted by physical exer

263 s, as well as the advantages of Nell-1 as an osteogenic protein with antiadipogenic, anti-inflammator

264 olds demonstrated volumetrically significant osteogenic regeneration of calvarial and alveolar defect

265 Deficiency of Cx43 delayed mesenchymal and osteogenic regeneration while in vivo AMPK inhibition in

266 liferation of pre-osteoblasts, and stimulate osteogenic regulator/marker expression.

267 ity within diabetes, involving activation of osteogenic regulators and transcription factors.

268 rtant role of the proteasomal degradation of osteogenic regulators, while the underlying molecular me

269 1 by siRNA led to an increased expression of osteogenic related genes, elevated alkaline phosphatase

270 f histone H3K9 acetylation and activation of osteogenic related genes.

271 to healthy levels rescues the epigenetic and osteogenic response in hMSCs with pathological nuclear m

272 electrical field stimulation (EFS)-enhanced osteogenic response in osteoprogenitor cells.

273 te the role of primary cilia in EFS-enhanced osteogenic response of human adipose-derived stem cells

274 to knockdown BMP-2 production abrogated the osteogenic response to levels observed with MSCs alone.

275 s, preventing bone fractures and inducing an osteogenic response with new bone formation.

276 n levels, and knockdown of RUNX2 reduced the osteogenic role of T63.

277 ated respectively with greater expression of osteogenic RUNX2 and with lower expression of several in

278 Bone osteogenic sarcoma has a poor prognosis as the exact cel

279 The loss of osteogenic signalling in C2C12 does not translate into n

280 last cells, P3 had no effect on BMP9-induced osteogenic signalling, which is primarily mediated by AL

281 icone gels we show that harder gels are more osteogenic, softer gels are more adipogenic, and cell sp

282 In addition, the expression of osteogenic specific genes alkaline phosphatase (ALP), Ru

283 rinted by accurate positioning of a layer of osteogenic spheroids onto a sacrificial alginate support

284 three dimensions (3D) into chondrogenic and osteogenic spheroids, which were confirmed by immunostai

285 Treatment with p38 inhibitors following osteogenic stimulation efficiently induced osteoblast di

286 hese data suggest that miR-101 is induced by osteogenic stimuli and promotes osteogenic differentiati

287 ace (tissue culture plastic) with or without osteogenic supplements.

288 With the achievements on Nell-1's osteogenic therapeutic evaluations from multiple preclin

289 ocked and that differentiation switches from osteogenic to chondrogenic, a process that could be mimi

290 The osteogenic transcription factor RUNX2 was quantified wit

291 The osteogenic transcription factor, Runx2, is abnormally ex

292 iRNA transfection promoted the expression of osteogenic transcription factors in normal jaw bone MSCs

293 ylates and induces the nuclear import of the osteogenic transcription regulator nuclear factor of act

294 Cre expressing cells as a cell of origin for osteogenic tumor and suggested the LKB1-mTORC1 pathway a

295 Here, we report an osteogenic tumor mouse model based on the conditional kn

296 thway as a promising target for treatment of osteogenic tumor.

297 ating the component cell interactions in the osteogenic-vascular niche and the role of exogenous fact

298 osteoblasts are expanded independent of the osteogenic vasculature in response to zoledronic acid.

299 age occurred independently of effects on the osteogenic vasculature.

300 Tregs stimulated production of the osteogenic Wnt ligand Wnt10b by BM CD8+ T cells, which a